Figure 1.
Figure 1. Proposed schema for use of anti-CD19 CAR T-cell therapy in clinical practice. PR, partial response; Rx, treatment. *Proceed to salvage 2 or CAR T-cell therapy. †Proceed to salvage 2, CAR T-cell therapy, or ASCT. ‡Proceed to CAR T-cell therapy ± salvage 3.

Proposed schema for use of anti-CD19 CAR T-cell therapy in clinical practice. PR, partial response; Rx, treatment. *Proceed to salvage 2 or CAR T-cell therapy. †Proceed to salvage 2, CAR T-cell therapy, or ASCT. ‡Proceed to CAR T-cell therapy ± salvage 3.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal